{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T15:22:03Z","timestamp":1649172123254},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.therap.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T20:46:07Z","timestamp":1555101967000},"page":"680-682","source":"Crossref","is-referenced-by-count":1,"title":["Insulin-induced lipodystrophy and interest of insulin injection ports"],"prefix":"10.1016","volume":"74","author":[{"given":"Asma","family":"Ben Abdelkrim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neila","family":"Fathallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujib","family":"Omri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosra","family":"Hasni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safa","family":"Khaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Kacem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molka","family":"Chaieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaker","family":"Ben Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amel","family":"Maaroufi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koussay","family":"Ach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.therap.2019.04.002_bib0045","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diacare.25.3.634","article-title":"Lipohypertrophy in young patients with type 1 diabetes","volume":"25","author":"Kordonouri","year":"2002","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.therap.2019.04.002_bib0050","first-page":"1196","article-title":"Frequency of lipodystrophy induced by recombinant human insulin","volume":"15","author":"Hajheydari","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.therap.2019.04.002_bib0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diabres.2006.12.023","article-title":"Incidence of lipohypertrophy in diabetic patients and a study of influencing factors","volume":"77","author":"Vardar","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.therap.2019.04.002_bib0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.therap.2016.02.010","article-title":"Causality assessment in pharmacovigilance: the French method and its successive updates","volume":"71","author":"Miremont-Salam\u00e9","year":"2016","journal-title":"Therapie"},{"issue":"5","key":"10.1016\/j.therap.2019.04.002_bib0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.diabet.2013.05.006","article-title":"Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes","volume":"39","author":"Blanco","year":"2013","journal-title":"Diabetes Metab"},{"issue":"3","key":"10.1016\/j.therap.2019.04.002_bib0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1753-0407.2010.00077.x","article-title":"Results and analysis of the 2008\u20132009 Insulin Injection Technique Questionnaire survey","volume":"2","author":"De Coninck","year":"2010","journal-title":"J Diabetes"},{"issue":"8","key":"10.1016\/j.therap.2019.04.002_bib0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/s-2001-18991","article-title":"Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes","volume":"109","author":"Raile","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"10.1016\/j.therap.2019.04.002_bib0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2337\/diaspect.21.3.197","article-title":"A study assessing an injection port for administration of insulin","volume":"21","author":"Blevins","year":"2008","journal-title":"Diabetes Spectrum"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571930068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004059571930068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T10:05:41Z","timestamp":1573812341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004059571930068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S004059571930068X"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2019.04.002","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}